4//SEC Filing
Heier Jeffrey S. 4
Accession 0001104659-23-072400
CIK 0001393434other
Filed
Jun 15, 8:00 PM ET
Accepted
Jun 16, 7:02 PM ET
Size
7.8 KB
Accession
0001104659-23-072400
Insider Transaction Report
Form 4
Heier Jeffrey S.
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-06-14+36,000→ 36,000 totalExercise: $5.31Exp: 2033-06-13→ Common Stock (36,000 underlying) - Award
Common Stock
2023-06-14+12,000→ 59,933 total
Footnotes (2)
- [F1]On June 14, 2023, the reporting person was granted restricted stock units ("RSUs") under the 2021 Stock Incentive Plan, as amended, of Ocular Therapeutix, Inc. (the "Company"). Each RSU represents a right to receive one share of the Company's common stock. Subject to the reporting person's continued service on the Company's board of directors, the RSUs will vest with respect to 100% of the shares underlying the RSUs on the first anniversary of the grant date or, if earlier, immediately prior to the next annual meeting of stockholders occurring after the grant date.
- [F2]Subject to the reporting person's continued service on the Company's board of directors, the options will vest with respect to 100% of the shares underlying the options on the first anniversary of the grant date or, if earlier, immediately prior to the next annual meeting of stockholders occurring after the grant date.
Documents
Issuer
OCULAR THERAPEUTIX, INC
CIK 0001393434
Entity typeother
Related Parties
1- filerCIK 0001653082
Filing Metadata
- Form type
- 4
- Filed
- Jun 15, 8:00 PM ET
- Accepted
- Jun 16, 7:02 PM ET
- Size
- 7.8 KB